The Synthetic Biology Consortium was formed as a place for researchers and stakeholders interested in the synthetic biology field to interact and share ideas with each other, as well as to facilitate bringing synthetic biology research to NIH.
Previous
Next
The 2020 Synthetic Biology Consortium Meeting will be held on November 9-10, 2020 in the Natcher Conference Center on NIH Main Campus in Bethesda, MD.
Hotel Information
|
Time |
Session |
Room Assignment |
|||
|
8:00am - 8:40am |
Registration |
Lower Level Lobby | |||
|
8:40am - 9:00am |
Welcoming Remarks Bruce Tromberg, NIBIB Institute Director | ||||
Current developments in synthetic biology have offered tools to design or modify organisms that can be used for a specific function, allowing for natural biological systems to be tailored as machines that produce desired compounds. Further, synthetic biology has a broad application and can be used to synthesize biologically relevant compounds and therapeutics that are not easily and/or not cost-effectively produced in a traditional laboratory setting.
This Funding Opportunity Announcement (FOA) invites applications to conduct research to advance the understanding and application of synthetic biology for human health. It will support 1) the development of innovative tools and technologies in synthetic biology and 2) their application in biomedical research and human health. An integrative research plan based on collaborations of synthetic biologists with computational scientists, cell biologists, engineers, and/or physician scientists is strongly recommended.
